MC
MCRXF.US Micro-X Limited
- Market cap
- USD 8.13M
- P/E
- -
- P/B
- 2.40x
- ROE
- -199.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is MCRXF.US undervalued?
Graham numberThe Graham number of Micro-X Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Micro-X Limited fundamental analysis
No fundamental analysis for Micro-X Limited yet.
Micro-X Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Micro-X Limited
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover …
Full company profileMicro-X Limited financial statements
Micro-X Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.93M | 4.25M | 3.77M | 8.97M | 15.0M | 15.2M | 13.1M | 15.1M |
| Gross Profit | 169K | 700K | -140K | 5.00M | 11.5M | 9.45M | 10.3M | 9.92M |
| Operating Income | -13.2M | -12.5M | -17.1M | -20.9M | -17.9M | -16.3M | -17.1M | -18.4M |
| EBITDA | -8.60M | -7.25M | -11.7M | -15.4M | -8.83M | -7.98M | -11.8M | -7.98M |
| Net Income | -9.83M | -10.1M | -14.7M | -17.1M | -10.8M | -9.77M | -13.9M | -9.88M |
| EPS | -0.06 | -0.03 | -0.03 | -0.04 | -0.02 | -0.02 | -0.02 | -0.01 |
| Balance Sheet | ||||||||
| Total Assets | 9.87M | 33.7M | 44.7M | 31.3M | 30.3M | 26.9M | 22.1M | 19.7M |
| Total Liabilities | 12.8M | 18.8M | 10.5M | 12.0M | 13.1M | 13.2M | 14.6M | 14.8M |
| Shareholders' Equity | -2.98M | 14.9M | 34.2M | 19.3M | 17.2M | 14.3M | 7.55M | 4.96M |
| Cash & Short-term Investments | 1.61M | 18.3M | 30.1M | 10.3M | 5.22M | 3.23M | 3.24M | 3.14M |
| Cash Flow | ||||||||
| Operating Cash Flow | - | -9.46M | -10.1M | -18.1M | -11.0M | - | - | - |
| Capital Expenditure | 1.71M | 2.13M | 783K | 1.06M | 779K | 369K | 100K | 144K |
| Free Cash Flow | -8.86M | -11.7M | -10.8M | -19.2M | -11.8M | -6.80M | -8.69M | -9.07M |
| Ratios | ||||||||
| ROE | - | -67.6% | -43.1% | -88.6% | -62.5% | -68.5% | -184.1% | -199.3% |
| ROA | -99.6% | -29.9% | -33.0% | -54.6% | -35.5% | -36.3% | -62.9% | -50.1% |
| Net Profit Margin | -509.3% | -236.8% | -390.6% | -190.5% | -71.7% | -64.2% | -106.5% | -65.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Micro-X Limited dividends
Micro-X Limited has not paid dividends in the last 8 fiscal years.
Who owns Micro-X Limited
- Insiders 29.83%
- Institutions 22.58%
- Public & others 47.59%
- Shares outstanding 753M
- Free float 537M
Micro-X Limited company profile
- Company name
- Micro-X Limited
- Ticker
- MCRXF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- June
- Address
- A14, 6 MAB Eastern Promenade, Adelaide, SA, Australia, 5042
- Phone
- 61 8 7099 3966
- Website
- micro-x.com
About Micro-X Limited
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; and imaging chains and custom X-ray imaging solutions, as well as engineering contract services and spare parts. The company has a strategic partnership with Billion Prima to develop and commercialize a baggage and parcel scanner product. Micro-X Limited was incorporated in 2011 and is based in Adelaide, Australia.
Micro-X Limited management
4- Dr. Brian Gonzales Ph.D.Chief Executive Officer
- Mr. Peter DickmanChief Financial Officer
- Mr. Anthony Skeats MEng (Hons)Chief Operating Officer
- Mr. Richard Walter-Cumming Willson B.Ac., B.Acc, C.P.A., FAICD, FCPA, G.A.I.C.D.Company Secretary